Dr. Spiekerkoetter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Drive RM H3143a
Stanford University Department of Medicine PCCM
Stanford, CA 94305Phone+1 650-723-6381
Summary
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2009
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2008
- Albert Ludwigs University Faculty of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 2009 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- FK506 (Tacrolimus) in Pulmonary Arterial Hypertension Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- 18 citationsSevere Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency.Andrew J. Sweatt, Kazuya Miyagawa, Christopher J. Rhodes, Shalina Taylor, Patricia A. del Rosario
Chest. 2021-06-26 - 85 citationsLow-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension.Edda Spiekerkoetter, Yon K. Sung, Deepti Sudheendra, Matthew Bill, Micheala A. Aldred
American Journal of Respiratory and Critical Care Medicine. 2015-07-15 - 310 citationsFK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertensionEdda Spiekerkoetter, Xuefei Tian, Jie Cai, Rachel K. Hopper, Deepti Sudheendra
The Journal of Clinical Investigation. 2013-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: